Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J J Cush

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Arthritis and Rheumatism|August 1, 1993
Increased levels of circulating intercellular adhesion molecule 1 in the sera of patients with rheumatoid arthritisJ J Cush, R Rothlein, H B Lindsley, et al.
The Journal of Rheumatology|November 1, 1993
The effects of nonsteroidal antiinflammatory drug therapy in early rheumatoid arthritis on serum levels of soluble interleukin 2 receptor, CD4, and CD8M A Dooley, J J Cush, P E Lipsky, et al.
Arthritis and Rheumatism|February 1, 1987
Adult-onset Still's disease. Clinical course and outcomeJ J Cush, T A Medsger, W C Christy, et al.
Arthritis and Rheumatism|January 1, 1990
Correlation of serologic indicators of inflammation with effectiveness of nonsteroidal antiinflammatory drug therapy in rheumatoid arthritisJ J Cush, P E Lipsky, A E Postlethwaite, et al.
Arthritis and Rheumatism|January 1, 1995
Elevated interleukin-10 levels in patients with rheumatoid arthritisJ J Cush, J B Splawski, R Thomas, et al.
Annals of the Rheumatic Diseases|April 15, 2004
A multicentre, double blind, randomised, placebo controlled trial of anakinra (Kineret), a recombinant interleukin 1 receptor antagonist, in patients with rheumatoid arthritis treated with background methotrexateS B Cohen, L W Moreland, J J Cush, et al.
The Journal of Rheumatology|June 21, 2001
Consensus recommendations for the assessment and treatment of rheumatoid arthritisF Wolfe, J J Cush, J R O'Dell, et al.
Arthritis and Rheumatism|July 1, 1996
A double-blind, placebo-controlled study of anti-CD5 immunoconjugate in patients with rheumatoid arthritis. The Xoma RA Investigator GroupN J Olsen, R H Brooks, J J Cush, et al.
Arthritis and Rheumatism|December 1, 1996
Comparison of sulfasalazine and placebo in the treatment of psoriatic arthritis. A Department of Veterans Affairs Cooperative StudyD O Clegg, D J Reda, E Mejias, et al.
Arthritis and Rheumatism|December 1, 1996
Comparison of sulfasalazine and placebo in the treatment of ankylosing spondylitis. A Department of Veterans Affairs Cooperative StudyD O Clegg, D J Reda, M H Weisman, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Arthritis and Rheumatism|August 1, 1993
Increased levels of circulating intercellular adhesion molecule 1 in the sera of patients with rheumatoid arthritisJ J Cush, R Rothlein, H B Lindsley, et al.
The Journal of Rheumatology|November 1, 1993
The effects of nonsteroidal antiinflammatory drug therapy in early rheumatoid arthritis on serum levels of soluble interleukin 2 receptor, CD4, and CD8M A Dooley, J J Cush, P E Lipsky, et al.
Arthritis and Rheumatism|February 1, 1987
Adult-onset Still's disease. Clinical course and outcomeJ J Cush, T A Medsger, W C Christy, et al.
Arthritis and Rheumatism|January 1, 1990
Correlation of serologic indicators of inflammation with effectiveness of nonsteroidal antiinflammatory drug therapy in rheumatoid arthritisJ J Cush, P E Lipsky, A E Postlethwaite, et al.
Arthritis and Rheumatism|January 1, 1995
Elevated interleukin-10 levels in patients with rheumatoid arthritisJ J Cush, J B Splawski, R Thomas, et al.
Annals of the Rheumatic Diseases|April 15, 2004
A multicentre, double blind, randomised, placebo controlled trial of anakinra (Kineret), a recombinant interleukin 1 receptor antagonist, in patients with rheumatoid arthritis treated with background methotrexateS B Cohen, L W Moreland, J J Cush, et al.
The Journal of Rheumatology|June 21, 2001
Consensus recommendations for the assessment and treatment of rheumatoid arthritisF Wolfe, J J Cush, J R O'Dell, et al.
Arthritis and Rheumatism|July 1, 1996
A double-blind, placebo-controlled study of anti-CD5 immunoconjugate in patients with rheumatoid arthritis. The Xoma RA Investigator GroupN J Olsen, R H Brooks, J J Cush, et al.
Arthritis and Rheumatism|December 1, 1996
Comparison of sulfasalazine and placebo in the treatment of psoriatic arthritis. A Department of Veterans Affairs Cooperative StudyD O Clegg, D J Reda, E Mejias, et al.
Arthritis and Rheumatism|December 1, 1996
Comparison of sulfasalazine and placebo in the treatment of ankylosing spondylitis. A Department of Veterans Affairs Cooperative StudyD O Clegg, D J Reda, M H Weisman, et al.
Pageof 4